Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study. J Clin Oncol. 2009 Aug 10; 27(23):3836-41.